InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: misiu143 post# 155036

Friday, 03/26/2021 9:57:49 PM

Friday, March 26, 2021 9:57:49 PM

Post# of 233144

Why you think they excluding patients with ALL secondary infections ??


Some of those secondary infections could hurt patients without it being lenzulimab's fault. Why sabotage the trial with illnesses out of your control?

Mayo Clinic had 12 patients total ,
No one can say anything about safety of a drug after evaluating 12 patients..


1. None of the 12 Mayo patients had any safety issues

2. Academics from Mayo Clinic believe lenz has no safety issues

3. The trial wasn't stopped over safety issues. If fact, it was allowed to change endpoints and add patients which is only allowed when the DSMC believes that the trial is showing promise.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News